Yousif Capital Management LLC Has $6.68 Million Stake in HCA Healthcare, Inc. (NYSE:HCA)

Yousif Capital Management LLC decreased its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 5.7% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 19,344 shares of the company's stock after selling 1,169 shares during the quarter. Yousif Capital Management LLC's holdings in HCA Healthcare were worth $6,684,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Principal Financial Group Inc. boosted its stake in HCA Healthcare by 120.1% during the fourth quarter. Principal Financial Group Inc. now owns 873,775 shares of the company's stock valued at $262,264,000 after buying an additional 476,756 shares during the last quarter. Brighton Jones LLC purchased a new position in HCA Healthcare during the 4th quarter worth $1,021,000. OLD National Bancorp IN increased its holdings in HCA Healthcare by 5.2% during the 1st quarter. OLD National Bancorp IN now owns 1,049 shares of the company's stock worth $362,000 after purchasing an additional 52 shares during the period. ABC Arbitrage SA bought a new stake in HCA Healthcare during the 4th quarter valued at $1,511,000. Finally, Savant Capital LLC boosted its position in HCA Healthcare by 4.1% during the 4th quarter. Savant Capital LLC now owns 3,673 shares of the company's stock valued at $1,102,000 after acquiring an additional 146 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company's stock.

HCA Healthcare Stock Down 0.2%

Shares of NYSE:HCA traded down $0.91 during trading on Friday, reaching $370.76. 872,296 shares of the company traded hands, compared to its average volume of 1,452,711. The firm has a fifty day simple moving average of $358.43 and a 200 day simple moving average of $333.18. The firm has a market cap of $89.20 billion, a P/E ratio of 16.88, a price-to-earnings-growth ratio of 1.10 and a beta of 1.49. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its earnings results on Friday, April 25th. The company reported $6.45 EPS for the quarter, topping the consensus estimate of $5.75 by $0.70. The firm had revenue of $18.32 billion for the quarter, compared to the consensus estimate of $18.26 billion. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. The business's quarterly revenue was up 5.7% on a year-over-year basis. During the same quarter last year, the firm posted $5.36 EPS. Analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Monday, June 16th will be paid a $0.72 dividend. The ex-dividend date of this dividend is Monday, June 16th. This represents a $2.88 dividend on an annualized basis and a yield of 0.78%. HCA Healthcare's payout ratio is currently 12.81%.

Analysts Set New Price Targets

A number of brokerages have commented on HCA. Wall Street Zen raised HCA Healthcare from a "hold" rating to a "buy" rating in a research report on Monday, April 28th. Robert W. Baird restated a "neutral" rating and issued a $336.00 price target (down previously from $396.00) on shares of HCA Healthcare in a research note on Tuesday, April 15th. Morgan Stanley set a $410.00 price objective on HCA Healthcare and gave the stock an "equal weight" rating in a research note on Monday, June 9th. Royal Bank of Canada dropped their price target on HCA Healthcare from $384.00 to $376.00 and set an "outperform" rating for the company in a research report on Monday, April 28th. Finally, Baird R W lowered HCA Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Seven equities research analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, HCA Healthcare currently has an average rating of "Moderate Buy" and an average price target of $392.47.

Insider Activity at HCA Healthcare

In other news, COO Jon M. Foster sold 15,698 shares of the company's stock in a transaction that occurred on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the transaction, the chief operating officer now directly owns 12,646 shares in the company, valued at approximately $4,670,420.72. This represents a 55.38% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 1.30% of the stock is currently owned by insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.